Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Income | 2 | 2020 | 1564 | 0.79 | Why? |
| Infant Formula | 1 | 2019 | 64 | 0.75 | Why? |
| Economics | 1 | 2020 | 196 | 0.73 | Why? |
| Glaucoma, Open-Angle | 1 | 2019 | 55 | 0.73 | Why? |
| Archaea | 1 | 2017 | 30 | 0.71 | Why? |
| Retroelements | 1 | 2017 | 27 | 0.70 | Why? |
| Complex Regional Pain Syndromes | 1 | 2017 | 7 | 0.69 | Why? |
| Social Welfare | 1 | 2018 | 141 | 0.65 | Why? |
| Leptospirosis | 1 | 2017 | 103 | 0.62 | Why? |
| Analgesics, Non-Narcotic | 1 | 2017 | 164 | 0.60 | Why? |
| Cyclonic Storms | 1 | 2019 | 236 | 0.58 | Why? |
| Ketamine | 1 | 2017 | 112 | 0.58 | Why? |
| Glaucoma | 1 | 2019 | 225 | 0.57 | Why? |
| Metagenome | 1 | 2017 | 268 | 0.57 | Why? |
| Adaptation, Physiological | 1 | 2017 | 359 | 0.55 | Why? |
| Methadone | 1 | 2017 | 296 | 0.52 | Why? |
| Walking | 1 | 2017 | 442 | 0.48 | Why? |
| Delirium | 1 | 2020 | 1061 | 0.41 | Why? |
| Electronic Nicotine Delivery Systems | 1 | 2018 | 561 | 0.41 | Why? |
| Research Personnel | 1 | 2020 | 1037 | 0.41 | Why? |
| Milk, Human | 1 | 2019 | 956 | 0.41 | Why? |
| Disasters | 1 | 2019 | 760 | 0.40 | Why? |
| Minority Groups | 1 | 2020 | 1631 | 0.40 | Why? |
| Uncertainty | 1 | 2020 | 1888 | 0.39 | Why? |
| Cognitive Dysfunction | 1 | 2020 | 1389 | 0.38 | Why? |
| Pain Management | 1 | 2017 | 854 | 0.35 | Why? |
| Public Policy | 1 | 2020 | 1894 | 0.34 | Why? |
| Dementia | 1 | 2020 | 1861 | 0.33 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.32 | Why? |
| Poverty | 1 | 2018 | 2302 | 0.31 | Why? |
| Nanoparticles | 1 | 2017 | 2040 | 0.29 | Why? |
| Cause of Death | 1 | 2019 | 4823 | 0.28 | Why? |
| Drug Design | 1 | 2017 | 2627 | 0.27 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.24 | Why? |
| Research Design | 1 | 2019 | 5830 | 0.23 | Why? |
| Aerosols | 1 | 2018 | 5393 | 0.23 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.21 | Why? |
| Gross Domestic Product | 1 | 2020 | 134 | 0.20 | Why? |
| Financing, Organized | 1 | 2020 | 137 | 0.19 | Why? |
| Education, Graduate | 1 | 2020 | 118 | 0.19 | Why? |
| Starvation | 1 | 2019 | 34 | 0.19 | Why? |
| Dexmedetomidine | 1 | 2020 | 130 | 0.19 | Why? |
| Puerto Rico | 1 | 2019 | 177 | 0.18 | Why? |
| Child Care | 1 | 2020 | 209 | 0.18 | Why? |
| Lead | 1 | 2019 | 94 | 0.18 | Why? |
| Iraq | 1 | 2019 | 177 | 0.18 | Why? |
| History, 21st Century | 2 | 2018 | 1849 | 0.18 | Why? |
| Endotoxins | 1 | 2018 | 80 | 0.18 | Why? |
| Neurofibrillary Tangles | 1 | 2017 | 18 | 0.17 | Why? |
| Appalachian Region | 1 | 2017 | 44 | 0.17 | Why? |
| Gases | 1 | 2018 | 113 | 0.17 | Why? |
| Death Certificates | 1 | 2019 | 130 | 0.17 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.16 | Why? |
| Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 81 | 0.16 | Why? |
| Research Support as Topic | 1 | 2020 | 327 | 0.16 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.16 | Why? |
| tau Proteins | 1 | 2017 | 162 | 0.16 | Why? |
| Ciprofloxacin | 1 | 2017 | 130 | 0.16 | Why? |
| Metals | 1 | 2018 | 182 | 0.16 | Why? |
| Earthquakes | 1 | 2019 | 165 | 0.16 | Why? |
| Armed Conflicts | 1 | 2019 | 209 | 0.15 | Why? |
| Kenya | 1 | 2018 | 887 | 0.14 | Why? |
| Smoke | 1 | 2018 | 349 | 0.13 | Why? |
| Belgium | 1 | 2020 | 2064 | 0.13 | Why? |
| Superinfection | 1 | 2018 | 459 | 0.13 | Why? |
| Immune Tolerance | 1 | 2018 | 608 | 0.12 | Why? |
| Immunologic Deficiency Syndromes | 1 | 2017 | 368 | 0.12 | Why? |
| Prednisone | 1 | 2017 | 652 | 0.12 | Why? |
| Particle Size | 1 | 2017 | 1052 | 0.12 | Why? |
| Israel | 1 | 2020 | 2751 | 0.11 | Why? |
| History, 20th Century | 1 | 2018 | 1282 | 0.11 | Why? |
| Fractures, Bone | 1 | 2017 | 487 | 0.11 | Why? |
| Genome-Wide Association Study | 1 | 2018 | 1648 | 0.11 | Why? |
| Africa | 1 | 2019 | 2986 | 0.10 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2013 | 12361 | 0.10 | Why? |
| Early Diagnosis | 1 | 2018 | 2443 | 0.09 | Why? |
| Pain | 1 | 2017 | 1084 | 0.09 | Why? |
| Breast Feeding | 1 | 2019 | 1585 | 0.09 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.09 | Why? |
| Apoptosis | 1 | 2018 | 2335 | 0.09 | Why? |
| Multiple Organ Failure | 1 | 2018 | 1724 | 0.08 | Why? |
| Humans | 14 | 2020 | 930598 | 0.08 | Why? |
| Leadership | 1 | 2020 | 2241 | 0.08 | Why? |
| Alzheimer Disease | 1 | 2017 | 1020 | 0.08 | Why? |
| World Health Organization | 1 | 2019 | 4213 | 0.07 | Why? |
| Lymphocytes | 1 | 2018 | 3056 | 0.07 | Why? |
| Immunologic Memory | 1 | 2017 | 3362 | 0.07 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.07 | Why? |
| Disease Outbreaks | 1 | 2013 | 27595 | 0.07 | Why? |
| Epitopes | 1 | 2017 | 4113 | 0.07 | Why? |
| Animals | 3 | 2019 | 78931 | 0.07 | Why? |
| Hong Kong | 1 | 2013 | 3361 | 0.07 | Why? |
| Aging | 1 | 2019 | 3581 | 0.06 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.06 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.06 | Why? |
| Spain | 1 | 2020 | 15545 | 0.06 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.05 | Why? |
| Education, Distance | 1 | 2020 | 4956 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Communicable Diseases, Emerging | 1 | 2013 | 2523 | 0.05 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2013 | 2984 | 0.05 | Why? |
| Mice | 1 | 2018 | 21357 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Infant | 1 | 2019 | 30274 | 0.04 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.04 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.04 | Why? |
| Risk Assessment | 1 | 2019 | 25439 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.04 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.03 | Why? |
| Phosphorylation | 1 | 2017 | 1060 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
| Child | 1 | 2020 | 70012 | 0.03 | Why? |
| Female | 3 | 2020 | 380317 | 0.03 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.03 | Why? |
| Disease Transmission, Infectious | 1 | 2013 | 9044 | 0.02 | Why? |
| Male | 3 | 2020 | 367725 | 0.02 | Why? |
| SARS Virus | 1 | 2013 | 13021 | 0.02 | Why? |
| Global Health | 1 | 2013 | 13911 | 0.02 | Why? |
| Influenza, Human | 1 | 2013 | 10779 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2017 | 6049 | 0.02 | Why? |
| Binding Sites | 1 | 2017 | 6201 | 0.02 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
| Aged | 1 | 2017 | 215776 | 0.00 | Why? |
| Adult | 1 | 2017 | 244371 | 0.00 | Why? |
| Middle Aged | 1 | 2017 | 270681 | 0.00 | Why? |
Arnold's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(131)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_